Narrow band imaging for bladder cancer

Area of Science:

• Urology
• Endoscopic Imaging Technology
• Oncology

Background:

• Bladder cancer diagnosis and treatment rely heavily on endoscopic visualization.
• Non-muscle invasive bladder cancer (NMIBC) requires accurate detection and effective resection to prevent recurrence and progression.
• Conventional white light cystoscopy has limitations in visualizing subtle neoplastic lesions.

Purpose of the Study:

• To review the diagnostic accuracy of Narrow Band Imaging (NBI) cystoscopy compared to conventional white light cystoscopy for NMIBC.
• To evaluate the impact of NBI technology on treatment outcomes in transurethral resection of bladder tumors (TURBT).
• To assess the role of NBI in the follow-up protocols for NMIBC patients.

Main Methods:

• Systematic review of studies comparing NBI cystoscopy with white light cystoscopy for NMIBC diagnosis.
• Analysis of treatment outcomes, including residual tumor rates and recurrence, following NBI-assisted TURBT.
• Evaluation of reported sensitivity and specificity data for NBI versus conventional methods.

Main Results:

• NBI cystoscopy demonstrated improved sensitivity for detecting bladder tumors compared to white light cystoscopy.
• Lower specificity and a higher rate of false-positive findings were observed with NBI.
• NBI application in TURBT was associated with a positive impact, including fewer residual tumors and reduced recurrence rates at follow-up.

Conclusions:

• NBI cystoscopy offers enhanced visualization for NMIBC, potentially improving diagnostic accuracy.
• The technology shows promise in refining TURBT procedures and follow-up strategies for NMIBC.
• Further large-scale prospective studies are necessary to confirm the cost-effectiveness and long-term benefits of NBI in NMIBC management.